Go Pro
OTCMKTS:PBIO

Pressure BioSciences (PBIO) Stock Price, News & Analysis

Pressure BioSciences logo
$0.0002 0.00 (0.00%)
As of 09/21/2026

About Pressure BioSciences Stock (OTCMKTS:PBIO)

Advanced

Key Stats

Today's Range
$0.0002
▼
$0.0002
50-Day Range
N/A
52-Week Range
$0.00
▼
$0.20
Volume
N/A
Average Volume
1,464 shs
Market Capitalization
$8.59 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pressure BioSciences, Inc. develops pressure-based technologies and instruments for applications in life sciences, food and beverage, nutraceuticals, cosmetics, and other industries. The company’s platforms are designed to use controlled high-pressure processing to improve sample preparation, extraction, formulation, preservation, and the development of consumer and industrial products.

Its product portfolio has included Barocycler high-pressure systems and related consumables for laboratory and research applications. Pressure BioSciences has also focused on its Ultra Shear Technology platform, which uses high-pressure processing to create stable nanoemulsions and other formulations that may support products such as beverages, supplements, cosmetics, and topical formulations.

Founded in 2005 and headquartered in South Easton, Massachusetts, Pressure BioSciences serves research, commercial, and industrial customers. The company has marketed its technologies internationally through direct sales and distribution relationships. Richard T. Schumacher, the company’s founder, has served as its president and chief executive officer.

AI Generated. May Contain Errors.

Receive PBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pressure BioSciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PBIO Stock News Headlines

Pressure BioSciences Inc.
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel
The big blood pressure experiment
See More Headlines

PBIO Stock Analysis - Frequently Asked Questions

Pressure BioSciences' stock was trading at $0.0005 at the beginning of the year. Since then, PBIO stock has decreased by 60.0% and is now trading at $0.0002.

Pressure BioSciences Inc. (OTCMKTS:PBIO) posted its quarterly earnings data on Friday, February, 7th. The company reported ($0.15) earnings per share (EPS) for the quarter.

Shares of PBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pressure BioSciences investors own include Hydrofarm Holdings Group (HYFM), Advanced Micro Devices (AMD), Canopy Growth (CGC), Corbus Pharmaceuticals (CRBP) and Novavax (NVAX).

Company Calendar

Last Earnings
2/07/2025
Today
9/24/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
OTCMKTS:PBIO
CIK
830656
Employees
16
Year Founded
2004

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$1.98 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
42,970,000
Free Float
38,327,000
Market Cap
$8.59 thousand
Optionable
Not Optionable
Beta
5.76

Social Links

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (OTCMKTS:PBIO) was last updated on 9/25/2026 by MarketBeat.com Staff.
From Our Partners